This is a preview of subscription content, log in via an institution to check access.
References
Dereure O. Drug-induced skin pigmentation: epidemiology, diagnosis and treatment. Am J Clin Dermatol 2001; 2(4): 253–62
British National Formulary. No. 43. London: The Pharmaceutical Press, 2002 Mar
Susser WS, Whitaker-Worth DL, Grant-Kels JM. Mucocutaneous reactions to chemotherapy. J Am Acad Dermatol 1999; 40: 367–98
Eisen D, Hakim MD. Minocycline-induced pigmentation: incidence, prevention and management. Drug Saf 1998; 18: 431–40
Smith RW, Leppard B, Barnett NL, et al. Chrysiasis revisited: a clinical and pathological study. Br J Dermatol 1995; 131: 671–8
Sicari MC, Lebwohl M, Baral J, et al. Photoinduced dermal pigmentation in patients taking tricyclic antidepressants: histology, electron microscopy, and energy dispersive spectroscopy. J Am Acad Dermatol 1999; 40: 290–3
Atkin DH, Fitzpatrick RE. Laser treatment of imipramineinduced hyperpigmentation. J Am Acad Dermatol 2000; 43: 77–80
Rights and permissions
About this article
Cite this article
Drug-induced skin pigmentation not rare, but difficult to diagnose. Drugs Ther. Perspect 18, 10–13 (2002). https://doi.org/10.2165/00042310-200218120-00004
Published:
Issue Date:
DOI: https://doi.org/10.2165/00042310-200218120-00004